Archive | Health Professionals

Continued benefits of immunotherapy shown in advanced melanoma

Source: Medwire News, December 2018 medwireNews: An updated analysis of the CheckMate 067 trial shows continued survival benefits at 4 years with nivolumab plus ipilimumab or nivolumab monotherapy versus ipilimumab alone in patients with previously untreated advanced melanoma. The study findings are published in The Lancet Oncology and were also presented at the ESMO 2018 Congress in Munich, Germany. For the […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

AAD releases new guidelines for the tx of cutaneous melanoma

Source: Medical Express, December 2018 Susan M. Swetter, M.D., from Stanford University Medical Center in California, and colleagues reviewed the evidence and made treatment recommendations for patients with primary cutaneous melanoma. The researchers note that surgical excision is still the primary treatment modality for melanoma, while Mohs surgery or other forms of staged excision may […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Team studying rare disorder discovers novel way to target melanoma

Source: Eurek Alert, December 2018 While studying a rare genetic disorder called NGLY1 deficiency, University of North Texas Health Science Center (UNTHSC) researchers discovered a new targeted treatment for combating melanoma, a skin cancer that kills about 9,000 people in the United States each year. Their research was recently published in the British Journal of Cancer. […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Immunotherapy Particularly Effective Against Aggressive Hereditary Melanoma, Study Reports

Source: Immuno-oncology News, December 2018 Patients with hereditary melanoma associated with mutations in the CDKN2A gene respond well to immunotherapy, possible due to an increased mutational load in these tumors, a study suggests. The study, “Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations,” was published in the Journal of Medical Genetics. People with inherited mutations […]

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest